Literature DB >> 29597218

Membranes and Sorbents.

William R Clark, Dayong Gao, Anna Lorenzin, Claudio Ronco.   

Abstract

For continuous renal replacement therapy (CRRT), the extracorporeal filter provides solute depuration, fluid removal, and control of electrolyte and acid-base balance in critically ill patients with acute kidney injury (AKI). The membranes comprising CRRT filters are almost exclusively based on hollow fiber designs and, while adapted from the chronic hemodialysis field, have features that are specific to the requirements of CRRT nevertheless. In addition, these devices have evolved through the 40 years of CRRT in response to changes in clinical practice and the desire to extend the solute removal spectrum. For some critically ill patients, more targeted removal of specific compounds poorly cleared by standard CRRT can be attempted with techniques based on adsorption. Sorbent hemoperfusion is now being applied more broadly in critically ill patients, especially in those with sepsis and systemic inflammation. In this review, the manner in which CRRT membranes and extracorporeal sorbents have evolved over the past 40 years for the treatment of critically ill patients with AKI and other disorders is described.
© 2018 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29597218     DOI: 10.1159/000485603

Source DB:  PubMed          Journal:  Contrib Nephrol        ISSN: 0302-5144            Impact factor:   1.580


  5 in total

1.  Endocan is a reliable biomarker during continuous renal replacement therapy.

Authors:  Maxence Hureau; Alexandre Gaudet; Nathalie De Freitas Caires; Erika Parmentier; Julien Poissy; Thibault Duburcq; Philippe Lassalle; Daniel Mathieu
Journal:  Crit Care       Date:  2019-09-03       Impact factor: 9.097

Review 2.  Hemoperfusion in the intensive care unit.

Authors:  Zaccaria Ricci; Stefano Romagnoli; Thiago Reis; Rinaldo Bellomo; Claudio Ronco
Journal:  Intensive Care Med       Date:  2022-08-19       Impact factor: 41.787

Review 3.  The Supporting Role of Combined and Sequential Extracorporeal Blood Purification Therapies in COVID-19 Patients in Intensive Care Unit.

Authors:  Federico Nalesso; Federica L Stefanelli; Valentina Di Vico; Leda Cattarin; Irene Cirella; Giuseppe Scaparrotta; Francesco Garzotto; Lorenzo A Calò
Journal:  Biomedicines       Date:  2022-08-19

4.  Pharmacokinetics of meropenem in children with sepsis undergoing extracorporeal life support: A prospective observational study.

Authors:  Yixue Wang; Zhiping Li; Weiming Chen; Gangfeng Yan; Guangfei Wang; Guoping Lu; Chao Chen
Journal:  J Clin Pharm Ther       Date:  2021-01-21       Impact factor: 2.512

5.  Reliability of biomarkers of sepsis during extracorporeal therapies: the clinician needs to know what is eliminated and what is not.

Authors:  Patrick M Honore; Sebastien Redant; David De Bels
Journal:  Crit Care       Date:  2020-09-11       Impact factor: 9.097

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.